z-logo
Premium
Cryptolepine hydrochloride: a potent antimycobacterial alkaloid derived from Cryptolepis sanguinolenta
Author(s) -
Gibbons Simon,
Fallah Fatemeh,
Wright Colin W.
Publication year - 2003
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.1284
Subject(s) - antimycobacterial , alkaloid , traditional medicine , minimum inhibitory concentration , biology , pharmacognosy , antibiotics , microbiology and biotechnology , mycobacterium tuberculosis , medicine , tuberculosis , pharmacology , biological activity , botany , in vitro , biochemistry , pathology
The activity of cryptolepine hydrochloride, a salt of the main indoloquinoline alkaloid from the West African medicinal plant Cryptolepis sanguinolenta , was assessed against the fast growing mycobacterial species Mycobacterium fortuitum , which has recently been shown to be of use in the evaluation of antitubercular drugs. The low minimum inhibitory concentration (MIC) of this compound (16 µg/mL) prompted further evaluation against other fast growing mycobacteria namely, M. phlei , M. aurum , M. smegmatis , M. bovis BCG and M. abcessus and the MICs ranged over 2–32 µg/mL for these species. The strong activity of this agent, the need for new antibiotics with activity against Mycobacterium tuberculosis , coupled with the ethnobotanical use of C. sanguinolenta extracts to treat infections, highlight the potential of the cryptolepine template for development of antimycobacterial agents. Copyright © 2003 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom